Boston Partners Buys 5,787 Shares of Chemed Co. (NYSE:CHE)

Boston Partners increased its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 51.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 17,070 shares of the company's stock after acquiring an additional 5,787 shares during the quarter. Boston Partners owned approximately 0.11% of Chemed worth $9,046,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp raised its holdings in shares of Chemed by 0.8% during the third quarter. State Street Corp now owns 464,354 shares of the company's stock valued at $279,063,000 after purchasing an additional 3,564 shares during the period. Geode Capital Management LLC raised its stake in Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock worth $201,820,000 after buying an additional 15,791 shares during the period. Boston Trust Walden Corp boosted its holdings in Chemed by 10.0% in the fourth quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after acquiring an additional 22,105 shares in the last quarter. FMR LLC grew its stake in Chemed by 23.8% in the third quarter. FMR LLC now owns 238,616 shares of the company's stock valued at $143,401,000 after acquiring an additional 45,917 shares during the period. Finally, Copeland Capital Management LLC increased its holdings in shares of Chemed by 16.8% during the fourth quarter. Copeland Capital Management LLC now owns 151,623 shares of the company's stock valued at $80,330,000 after acquiring an additional 21,834 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Remove Ads

Insider Transactions at Chemed

In other Chemed news, VP Brian C. Judkins bought 145 shares of the business's stock in a transaction dated Monday, December 30th. The shares were purchased at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares of the company's stock, valued at approximately $871,721. This represents a 9.46 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares of the company's stock, valued at $60,957,441.93. The trade was a 1.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on CHE. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Stock Performance

CHE traded up $1.65 during midday trading on Tuesday, reaching $608.54. 123,742 shares of the company were exchanged, compared to its average volume of 89,101. The company has a market cap of $8.91 billion, a price-to-earnings ratio of 30.75, a price-to-earnings-growth ratio of 2.15 and a beta of 0.43. Chemed Co. has a one year low of $512.12 and a one year high of $648.29. The company's fifty day moving average price is $569.25 and its 200 day moving average price is $565.58.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date was Monday, February 24th. Chemed's dividend payout ratio is 10.05%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.